Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study

MLA

Yuji Kishimoto, et al. “Intensified Consolidation Therapy with Dose-Escalated Doxorubicin Did Not Improve the Prognosis of Adults with Acute Lymphoblastic Leukemia: The JALSG-ALL97 Study.” International Journal of Hematology, vol. 92, Sept. 2010, pp. 490–502. EBSCOhost, https://doi.org/10.1007/s12185-010-0672-z.

APA

Yuji Kishimoto, Masako Iwanaga, Shigeo Horiike, Masayuki Kato, Motohiro Tsuzuki, Kazunori Ohnishi, Hirokazu Okumura, Yasushi Miyazaki, Shuichi Miyawaki, Yasunori Ueda, Yasuhiro Maeda, Noriko Usui, Jin Takeuchi, Fumiharu Yagasaki, Tohru Sakura, R Ohno, Itsuro Jinnai, Taiichi Kyo, Kosuke Tsuboi, & Tomoki Naoe. (2010). Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study. International Journal of Hematology, 92, 490–502. https://doi.org/10.1007/s12185-010-0672-z

Chicago

Yuji Kishimoto, Masako Iwanaga, Shigeo Horiike, Masayuki Kato, Motohiro Tsuzuki, Kazunori Ohnishi, Hirokazu Okumura, et al. 2010. “Intensified Consolidation Therapy with Dose-Escalated Doxorubicin Did Not Improve the Prognosis of Adults with Acute Lymphoblastic Leukemia: The JALSG-ALL97 Study.” International Journal of Hematology 92 (September): 490–502. doi:10.1007/s12185-010-0672-z.